Free Account Opening + AMC Free Demat
Loading...

Aarti Drugs Buyback 2023 vs BSE Buyback July 2023

Comparision between Aarti Drugs Buyback 2023 and BSE Buyback July 2023.

Buyback Details

Aarti Drugs Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while BSE Buyback July 2023 is a Tender Offer proposed to list at NSE.

  Aarti Drugs Limited BSE Limited
Logo Aarti Drugs Buyback 2023 Logo BSE Buyback July 2023 Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE NSE
Face Value ₹10 per share ₹2 per share
Buyback Price ₹900 per share ₹1080 per share
Issue Size 6,65,000 shares 34,70,370 shares
Issue Size (Amount) ₹59.85 Crores ₹374.80 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders2 Equity Shares out of every 157 Fully paid-up Equity Shares held on the Record Date.99,750.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 150 Fully paid-up Equity Shares held on the Record Date.565,250.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders1 Equity Shares out of every 26 Fully paid-up Equity Shares held on the Record Date.520,556.00
General Category for all other Eligible Shareholders2 Equity Shares out of every 83 Fully paid-up Equity Shares held on the Record Date.2,949,814.00
Registrar Link Intime India Private Ltd Kfin Technologies Limited
Lead Managers Inga Ventures Pvt Ltd Nuvama Wealth Management Limited
Necessity of the buyback

The Buy Back is being proposed by the Company to fulfill the following objectives:

  1. The Buyback will help the company to return surplus cash to its shareholders holding Equity Shares.
  2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by a reduction in the equity base, thereby leading to a long-term increase in shareholders value.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the company, either to sell their Equity Shares and receive cash or not to sell their Equity Shares and get a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment.
  4. The Buyback, which is being implemented through the tender offer as prescribed under the Buyback Regulations, would involve a minimum reservation of 15% for Small Shareholders and allocation of a higher number of shares as per their entitlement or 15% of the number of shares to be bought back, reserved for the Small Shareholders. The Company believes that this reservation for Small Shareholders would benefit a large number of public shareholders, who would get classified as Small Shareholders.

The proposed Buy-back will help the Company achieve the following objectives:

  1. To return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
  2. The Buy Back, which is being implemented through the tender offer involving a reservation for Small Shareholders of 15%. The Company believes that this reservation of 15% for Small Shareholders would benefit a large number of public shareholders.
  3. The Buy Back may help in improving return on equity.
  4. The Buy Back gives an option to the shareholders holding Equity Shares of the Company, to either choose to participate and get cash in lieu of Equity Shares or choose not to participate and enjoy a resultant increase in their percentage shareholding.

Buyback Timetable

Aarti Drugs Buyback 2023 and BSE Buyback July 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2023 Buyback record date is Aug 04, 2023. BSE Buyback July 2023 Buyback record date is Sep 14, 2023.

  Aarti Drugs Limited BSE Limited
Record Date Aug 04, 2023 Sep 14, 2023
Offer Open Date Aug 09, 2023 Sep 21, 2023
Offer Closure Date Aug 17, 2023 Sep 27, 2023
Last date for receipt of tender forms Aug 17, 2023 Sep 27, 2023
Finalisation of buyback Aug 23, 2023 Oct 04, 2023
Last Date for settlment of bids Aug 24, 2023 Oct 05, 2023
Last Date for extinguishment of shares Sep 04, 2023 Oct 16, 2023

Financial Details and Other Relevent Information

Comparison of Aarti Drugs Buyback 2023 and BSE Buyback July 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Aarti Drugs Limited BSE Limited
Financial
Aarti Drugs Buyback 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 201931 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets1,455.491,576.501,766.012,207.962,421.40
Revenue1,436.091,626.752,159.312,499.962,718.25
Profit After Tax89.75141.40280.40205.00166.36
Net Worth904.271,026.521,184.10
Reserves and Surplus
Total Borrowing
Amount in ₹ Crore
BSE Buyback July 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets4,475.774,627.086,185.405,993.81
Revenue630.00654.65863.53953.94
Profit After Tax120.61141.70244.93205.65
Net Worth
Reserves and Surplus2,406.392,473.642,613.132,648.25
Total Borrowing
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2023 492.95 437.35 460.04
May-2023 478.25 423.00 452.48
Apr-2023 436.00 336.05 407.57
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2023 493.00 439.10 459.93
May-2023 478.00 422.85 452.23
Apr-2023 436.00 336.00 407.91

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Aug-2023 1084.90 804.00 893.05
Jul-2023 814.00 611.75 733.72
Jun-2023 624.30 551.45 579.01

Comments

Add a public comment...